STOCKS NEWS US-Immucor shares drop after FDA notice

Stocks on the move [HOT-RTRS]

Real-time Equity news [U][E][RESF/US]

For U.S. stock market report double-click [.N]
1058 ET 26June2009-Immucor shares tank after FDA notice
------------------------------------------------------------------------------

Shares of Immucor Inc (BLUD.O) plummeted on Friday after U.S. health
regulators issued a notice of intent to revoke the biologics license for some
of the company's blood reagents based on a January 2009 inspection.

The company said the notice was related to two of its blood products --
Reagent Red Blood Cells and Anti-E Blood (Monoclonal) Grouping Reagent product
-- that are used to detect antigen and antibody reactions. The two products are
mostly used by blood banks.

The Food and Drug Administration hasn't ordered the recall of any of the
products, Immucor said.

For details, see [ID:nBNG505296]

Shares of Immucor dropped 19 percent to $13.08.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net; Editing by
Kenneth Barry
1053 ET 26June2009-Markets fall on profit-taking, energy weakness
------------------------------------------------------------------------------

Major U.S. indexes fell on Friday, dropping as investors booked profits and
a fall in the price of crude oil pressured energy shares. For details, see
[ID:nN26328486]

The Dow Jones industrial average .DJI fell 0.7 percent to 8,411.56 while
the S&P 500 .SPX lost 0.7 percent to 914.04 and the Nasdaq .IXIC was off
0.3 percent to 1,823.94.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
1042 ET 26June2009-Susquehanna suggests Expedia volatility sales
------------------------------------------------------------------------------

Selling strangles in Expedia (EXPE.O) look attractive to capture high
volatility levels and enhance returns in the coming months, said Susquehanna
Financial Group's market intelligence team in a note. "With volatility in EXPE
elevated as a result of recent July $15 put buyers, we recommend long
shareholders who agree with SFG Internet analyst Marianne Wolk's positive
outlook on the stock take advantage by selling October $12.50 (put)/$20 (call)
strangles against positions," the note said. Over the last week, Expedia has
seen the greatest rise in 90-day implied volatility of any name within the
Nasdaq 100, they said. As of Thursday's close, the bid in the strangle was
$1.45, representing a 9 percent stand-still return between now and expiration
based on the stock price close of $15.79. Should shares stay rangebound between
$12.50 and $20, investors would fetch the $1.45 premium. Below $12.50, they
would be obligated to add to existing positions at a net effective price of
$11.05, which they believe would represent an attractive entry point. Above
$20, investors would be obligated to sell shares at $21.45, the note said.

Reuters Messaging: doris.frankel.reuters.com@reuters.net
1020 ET 26June2009-Crude oil falls, weighing on energy companies
------------------------------------------------------------------------------

August crude oil futures fell on Friday, dropping after Nigeria said it
would halt a battle with rebels during a 60-day amnesty period for militants
and release a suspected rebel leader if he accepted an amnesty offer.

The news reversed early sharp gains in the oil market which followed a
statement by Nigerian rebels that they had blown up a wellhead in a Royal Dutch
Shell (RDSa.L) oilfield.

For details, see [ID:nSIN249975]

The contract dropped 1.3 percent to $69.33 per barrel while the S&P Energy
index .GSPE was down 0.6 percent to 373.33.

Among specific oil companies, Dow components ExxonMobil (XOM.N) fell 0.7
percent to $69.40 while Chevron Corp (CVX.N) was off 0.8 percent to $66.31.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net
1017 ET 26June2009-Bove cuts 2009 earnings outlook on Goldman Sachs
------------------------------------------------------------------------------

Rochdale Securities analyst Richard Bove on Friday cut his 2009 earnings
estimates on Goldman Sachs to reflect the impact of the company repaying TARP
funds. Bove also expects the company to suffer a $1 billion loss on exposure to
commercial real estate.

The earnings view was cut to $14.95 a share from $15.71 a share.

Despite the lower estimate, Bove said the financial services company
appears to be having "a very good quarter."

For details, see [ID:nWNAB2568]

Shares of Goldman rose 1.3 percent to $146.37.

Reuters Messaging: ryan.vlastelica.reuters.com@reuters.net